Indies Pharma Jamaica Limited (JMSE: INDIES)
Jamaica
· Delayed Price · Currency is JMD 3.520
0.00 (0.00%)
At close: Feb 5, 2025
Indies Pharma Jamaica Revenue
In the fiscal year ending October 31, 2024, Indies Pharma Jamaica had annual revenue of 1.16B JMD with 9.81% growth. Indies Pharma Jamaica had revenue of 291.73M in the quarter ending October 31, 2024, with 8.63% growth.
Revenue
1.16B
Revenue Growth
+9.81%
P/S Ratio
4.05
Revenue / Employee
n/a
Employees
71
Market Cap
4.69B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scotia Group Jamaica | 59.12B |
| Sagicor Group Jamaica | 100.22B |
| NCB Financial Group | 120.01B |
| Pan Jamaica Group | 42.28B |
| Barita Investments | 9.40B |
| Wisynco Group | 55.18B |
| Caribbean Cement Company | 27.94B |
| GraceKennedy | 163.58B |